🇺🇸 FDA
Patent

US 8101637

Alkynyl derivatives as modulators of metatropic glutamate receptors

granted A61PA61P1/00A61P1/04

Quick answer

US patent 8101637 (Alkynyl derivatives as modulators of metatropic glutamate receptors) held by Addex Pharma, S.A. expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Addex Pharma, S.A.
Grant date
Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61P, A61P1/00, A61P1/04, A61P25/00, A61P25/04